Back Link
Reader View

Arcutis Biotherapeutics evp Masaru Matsuda sells $1.37M in planned share sale

www.investing.com · November 5, 2026 · 03:01
Paywall detected

This article has a paywall

The publisher blocks direct access to this article.

Open link